Receive all the news and alerts first. Sign up for the news letter :http://www.stocksource.us
For stock picks and investment community interaction please follow us on http://www.facebook.com/stockp and www.twitter.com/penny_stock
Viaspace Inc. (OTCBB:VSPC)
IRVINE, Calif., April 26, 2010 -- VIASPACE Inc (VSPC) today provided an update on its business of growing Giant King Grass as a low-carbon, renewable energy crop.
Giant King Grass is being cultivated on Company-leased land near Guangzhou in Guangdong province in southern China. Initial harvests have been used as nursery stock to provide seedlings, which have supported expansion of planted acreage to about 250 acres currently. This expanded nursery is capable of providing seedlings that could develop more than 10,000 acres of Giant King Grass fields.
From the initial harvests, samples have been sent to potential customers and partners. Samples have also been used to support the Company's product development, and its first Giant King Grass product is expected to be announced shortly.
VIASPACE Chief Executive Dr. Carl Kukkonen stated: "In China, we are directly involved in and control the entire process from land acquisition to manufacturing. We lease the land, hire farmers and other labor, harvest the crops, and manufacture the final product in our new, company-owned factory."
Follow our news and alerts with our newsletter sign up today: http://www.stocksource.us
Urigen Pharmaceuticals Inc. (OTCBB:URGP)
SAN FRANCISCO—April 26, 2010--Urigen Pharmaceuticals, Inc. (OTCBB: URGP), a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the secured debt held by Platinum-Montaur Life Sciences, LLC has been converted into a newly created Series C Preferred Stock of the Company. As a result of the conversion, the lien on the Company’s assets, including its intellectual property will be extinguished.
"This is an important event for Urigen and represents a vote of confidence by our key institutional investor," said Urigen's CEO, William J. Garner, MD.
Michael M. Goldberg, MD, Portfolio Manager, Platinum-Montaur Life Sciences, LLC, and a Director of Urigen, said, "With the filing for the URG101 FDA meeting, I believe that Urigen is making considerable progress and this is a step that we have taken to enhance the profile of the company to attract additional investment."
Sign up for our newsletter: http://www.stocksource.us
Element92 Resources Corp (OTCBB:ELRE)
CHEYENNE, Wyo. and HONG KONG, Apr 26, 2010 -- Element92 Resources Corp. (ELRE) announced today that it has executed a sales & purchase agreement to acquire a majority interest in Legarleon Precious Metals, Ltd. (LPM). Legarleon is a Hong Kong company that owns a seat on The Chinese Gold & Silver Society Exchange based in Hong Kong.
The Exchange provides local and international investors with a gold market of continuity, liquidity and depth, in which they can exploit gold as a vehicle of investment, speculation, hedging and arbitrage. The Exchange dates back to 1910 when it began operations as the "Gold and Silver Exchange Company" and plays a vital role in Hong Kong's gold market.
E92R will pay 2 million restricted shares for a 51% stake. The closing is scheduled for June 30, 2010 and is subject to due diligence and approval by The Chinese Gold & Silver Society Exchange's Board. "This acquisition is an important step for us and will allow the company to forward sell gold production as well as trade in gold futures," said President Daniel Mckinney. "This deal will help us facilitate our goal of becoming a fully integrated gold producer."
Follow our news and alerts with our newsletter sign up today: http://www.stocksource.us
ChromaDex Corp (OTCBB:CDXC)
IRVINE, Calif., April 26 -- ChromaDex Corporation (OTC Bulletin Board: CDXC), a natural products chemistry company which provides novel and innovative ingredients to the dietary supplement, food, beverage and cosmetic markets, announced today The Frost Group, LLC, led by Miami entrepreneur and billionaire Dr. Phillip Frost, has agreed to make an investment in ChromaDex. The amount of the investment was not disclosed.
The investment will allow ChromaDex to pursue clinical studies and commercialization for its new pTeroPure™ pterostilbene as well as to continue development of several other novel natural ingredients. ChromaDex separately announced today its has entered into an exclusive worldwide license with the University of Mississippi and the USDA Agricultural Research Service ("licensors") for all patent rights of pterostilbene (tero-STILL-bean), a promising botanical compound.
Pterostilbene, a derivative of resveratrol, is a botanical compound found in blueberries, grapes and other small fruits, as well as the bark of some trees. In laboratory tests, pterostilbene has shown promise for improving cardiovascular health, glucose levels, cognitive function, and possessing cancer-fighting properties. Various scientific publications have shown that pterostilbene has significantly higher activity compared to its brethren compound, resveratrol.
Sign up for our newsletter: http://www.stocksource.us
Nexaira Wireless Inc. (OTCBB:NXWI)
VANCOUVER, British Columbia—April 26,2010--Nexaira Wireless Inc., (“Nexaira”) (OTCBB:NXWI), a leading provider of wireless applications for business, announced today that it has appointed Bill Neale as Vice President Business Application Solutions of Nexaira Wireless (BC) Ltd., Nexaira’s Canadian subsidiary. Mr. Neale will be responsible for customer facing application solutions working with the sales and technical teams in both Canada and the US as Nexaira expands its business.
"Bill wlll be instrumental in assisting sales initiatives and channel development and most importantly will be focused on supporting our growing customer base and their unique uses of our products" said Mark Sampson, CEO and president of Nexaira. "Bill’s proven track record in product and service development and deployment in the telecommunications industry and his relationships with wireless and wireline carriers particularly in Canada will be key to us realizing our sales and business development initiatives."
For A Comprehensive Coverage of Stock Please Visit:
http://www.stocksource.us
E-mail: info@StockSource.us | Phone number: 858-750-9041
For stock picks and investment community interaction please follow us on http://www.facebook.com/stockp and www.twitter.com/penny_stock
StockSource.us offers a newsletter covering companies traded on the OTC, OTCBB, PINKSHEETS and AMEX stock exchanges. Subscribers to our newsletter will receive up to date time sensitive press releases and profiles on featured companies traded on various small cap stock exchanges such as otc, otcbb, pinksheet and amex. Other sectors we cover are: alternative energy stocks/companies (solar stocks, wind stocks, hydro stocks, nuclear stocks, uranium stocks, biofuel stocks, clean coal stocks) as well as oil and gas stocks, gold stocks and mining stocks.
Iron Consulting Inc. delivers a broad spectrum of services designed to meet your goals and fit your budget. They include: Search Engine Optimization, Email Campaigns, Financial News Distribution and Media Exposure, CEO Interviews, Analyst Reports, Investment Opinion Services, Web Design and Development, Audio & Video Profiles and Shareholder Communications.
StockSource.us is owned and operated by Iron Consulting.
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), StockSource.us is owned and operated by Iron Consulting. Iron Consulting has received twenty five thousand from Equity Alliance Intl. for a one month internet marketing program. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
(с) 2006 StockSource.us All Rights Reserved. Disclaimer
E-mail: info@StockSource.us
Phone number: 858-750-9041
